Lipofectamine® RNAiMAX Transfection Reagent

siRNA / RNAi /miRNA transfection Human - Jurkat cells Lipofectamine

Experiment
siRNA / RNAi /miRNA transfection Human - Jurkat cells Lipofectamine
Product
Lipofectamine® RNAiMAX Transfection Reagent from Thermo Fisher Scientific
Manufacturer
Thermo Fisher Scientific

Protocol tips

Protocol tips
siRNA sequence:sequences are 5′-CAUCUCCUAUGGCGGUGGU (siNB1i) and 5′-UGGUCCUCCUCAAGGCAGU (siNB2i)

Add diluted siRNA to diluted Lipofectamine® RNAiMAX Reagent (1:1 ratio). 

Incubate for 5 minutes at room temperature and add to cells. 

Incubate cells for 3 days at 37°C. 

Publication protocol

Two different siRNAs targeting Nullbasic were synthesized. The sequences are 5′-CAUCUCCUAUGGCGGUGGU (siNB1i) and 5′-UGGUCCUCCUCAAGGCAGU (siNB2i). To test the knockdown specificity and efficiency of the designed siRNAs, HeLa cells stably expressing either HIV-1 Tat or Nullbasic were transfected with siNB1i, siNB2i, and a universal negative-control siRNA (siCTRL) by using Lipofectamine RNAiMAX (Thermo Fisher, Waltham, MA) in accordance with the manufacturer’s instructions. Cells were incubated at 37°C for 72 h and then lysed in cell lysis buffer for Western blot analysis. A shRNA, shNB1i, that was based on the siNB1i sequence was constructed. An XbaI site was inserted into the sequence for screening, and the restriction sites HpaI and XhoI were added at the 5′ and 3′ ends, respectively. The shRNA fragments were ligated into pSicoR-Ef1a-mCh between the HpaI and XhoI sites downstream of a U6 promoter. The pSicoR.NBshRNA.mCh vector was confirmed by sequencing. VLPs containing shNB1i were made by cotransfecting HEK293T cells with 10 µg of plasmid pCMVΔR8.91, 3 µg of pCMV-VSV-G, and 3 µg of pSicoR.NBshRNA.mCh. Two rounds of transduction were performed, and flow cytometry showed that >90% of the cells were successfully transduced. The cells were grown for 72 h, after which cells were collected and a lysate was prepared as described previously. The culture supernatant was collected and analyzed for HIV-1 CA by ELISA.

Full paper   Login or join for free to view the full paper.

Reviews

Lipofectamine® RNAiMAX Transfection Reagent from Thermo Fisher Scientific has not yet been reviewed for this experiment

We'd love it if you would be the first to write a review!

Discussion

Discussion

1 year ago

Author: Keith L. Morrison Canada

siRNA/RNAi/miRNA transfection human

I would like to regulate the expression of a gene and in order to do that, I have purchased specific siRNA. After optimizing my transfection protocol and using electroporation I have achieved a 60-70% reduction of the gene of interest. However, I cannot observe a significant reduction of mRNA expression but only a reduction of protein. What might be the problem? Could the problem be in my cell treatment method?

Share your thoughts or question with experts in your field by adding a discussion!

Papers

Check out relevant papers found by Labettor's AI that are relevant for performing siRNA / RNAi /miRNA transfection Human - Jurkat cells Lipofectamine using Lipofectamine® RNAiMAX Transfection Reagent from Thermo Fisher Scientific.

View full paper   Login or join for free to view the full paper.

Manufacturer protocol

Download the product protocol from Thermo Fisher Scientific for Lipofectamine® RNAiMAX Transfection Reagent below.

Download PDF Download manufacturer protocol

Videos

Check out videos that might be relevant for performing siRNA / RNAi /miRNA transfection Human - Jurkat cells Lipofectamine using Lipofectamine® RNAiMAX Transfection Reagent from Thermo Fisher Scientific. Please note that these videos are representative and steps or experiment specific processes must be kept in mind to expect desired results.

We haven't found any additional videos for this experiment / product combination yet.

Become shareholder Discussions About us Contact Privacy Terms